alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4555 Referred in Senate (RFS)]

<DOC>
115th CONGRESS
  2d Session
                                H. R. 4555

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            January 10, 2018

Received; read twice and referred to the Committee on Homeland Security 
                        and Governmental Affairs

_______________________________________________________________________

                                 AN ACT

 
To authorize the participation in overseas interagency counterterrorism 
 task forces of personnel of the Department of Homeland Security, and 
                          for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``DHS Interagency Counterterrorism 
Task Force Act of 2017''.

SEC. 2. OVERSEAS INTERAGENCY COUNTERTERRORISM TASK FORCE PARTICIPATION.

    Section 102 of the Homeland Security Act of 2002 (6 U.S.C. 112) is 
amended by adding at the end the following new subsection:
    ``(h) Coordination With Other Federal Departments and Agencies 
Overseas.--
            ``(1) In general.--The Secretary is authorized to assign 
        Department personnel to participate in overseas interagency 
        counterterrorism task forces to--
                    ``(A) facilitate the sharing of counterterrorism 
                information, and
                    ``(B) combat the threat of terrorism and associated 
                risks to the United States stemming from overseas 
                sources of conflict or terrorism,
        as determined by the Secretary.
            ``(2) Personnel.--In carrying out this subsection, the 
        Secretary may assign personnel from any component of the 
        Department the Secretary determines necessary to participate in 
        the overseas counterterrorism task forces referred to in 
        paragraph (1).''.

SEC. 3. ANNUAL REPORTS.

    Not later than 18 months after the date of the enactment of this 
Act and annually thereafter for 3 years, the Secretary of Homeland 
Security shall report to the Committee on Homeland Security, the 
Committee on Foreign Affairs, the Permanent Select Committee on 
Intelligence, and the Committee on Armed Services of the House of 
Representatives and the Committee on Homeland Security and Governmental 
Affairs, the Committee on Foreign Relations, Select Committee on 
Intelligence, and the Committee on Armed Services of the Senate on 
activities carried out pursuant to subsection (h) of section 102 of the 
Homeland Security Act of 2002 (6 U.S.C. 112), as added by section 2 of 
this Act.

            Passed the House of Representatives January 9, 2018.

            Attest:

                                                 KAREN L. HAAS,

                                                                 Clerk.
```
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                          63,079
<SECURITIES>                                       148
<RECEIVABLES>                                   34,467
<ALLOWANCES>                                     3,923
<INVENTORY>                                          0
<CURRENT-ASSETS>                               114,268
<PP&E>                                          20,058
<DEPRECIATION>                                   8,473
<TOTAL-ASSETS>                                 215,367
<CURRENT-LIABILITIES>                           91,508
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           701
<OTHER-SE>                                     119,492
<TOTAL-LIABILITY-AND-EQUITY>                   215,367
<SALES>                                         56,527
<TOTAL-REVENUES>                                79,200
<CGS>                                            4,640
<TOTAL-COSTS>                                  111,199
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                   790
<INTEREST-EXPENSE>                             (4,887)
<INCOME-PRETAX>                               (27,112)
<INCOME-TAX>                                       380
<INCOME-CONTINUING>                           (27,492)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (27,492)
<EPS-BASIC>                                     (0.42)
<EPS-DILUTED>                                   (0.42)


</TABLE>
# C_2008116EN.01003303.xml

| 9.5.2008 | EN | Official Journal of the European Union | C 116/33 |
| --- | --- | --- | --- |

9.5.2008

EN

Official Journal of the European Union

C 116/33

---

Action brought on 18 February 2008 — Di Bucci v Commission

(Case F-23/08)

(2008/C 116/64)

Language of the case: French

Parties

Applicant: Vittorio Di Bucci (Brussels, Belgium) (represented by: M. van der Woude, lawyer)

Applicant:

Defendant: Commission of the European Communities

Defendant:

The subject-matter and description of the proceedings

Annulment of the decision of 11 April 2007 in so far as it awards the applicant a single additional priority point in the 2003 Promotion procedure, making a total of 2 priority points and a grand total of 21 points, and an order that the defendant pay compensation.

Form of order sought

| — | Annul the decision of 11 April 2007 in so far as it awards the applicant a single additional priority point in the 2003 Promotion procedure, making a total of 2 priority points and a grand total of 21 points, and order that the defendant pay compensation; |
| --- | --- |

—

Annul the decision of 11 April 2007 in so far as it awards the applicant a single additional priority point in the 2003 Promotion procedure, making a total of 2 priority points and a grand total of 21 points, and order that the defendant pay compensation;

| — | order the defendant to pay damages of EUR 5 000; |
| --- | --- |

—

order the defendant to pay damages of EUR 5 000;

| — | order the Commission of the European Communities to pay the costs. |
| --- | --- |

—

order the Commission of the European Communities to pay the costs.

---
```

[Congressional Record Volume 158, Number 120 (Monday, September 10, 2012)]
[House]
[Page H5765]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

            By Mr. THOMPSON of California:
        H.R. 6362.
        Congress has the power to enact this legislation pursuant 
     to the following:
       The Congress shall have Power to make all Laws which shall 
     be necessary and proper for carrying into Execution the 
     foregoing Powers, and all other Powers vested by the 
     Constitution in the Government of the United States, or in 
     any Department or Officer thereof.
```
**EXHIBIT
      32.1**






**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. 1350,**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**






In
      connection with the Quarterly Report of  A J&J PHARMA CORPORATION,
      (the "Company") on Form 10-QSB for the period ended June 30, 2007 as filed
      with the Securities and Exchange Commission on the date hereof (the "Report"),
      I, Kevin Ericksteen, Chief Executive Officer and Chief Financial Officer of
      the
      Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section
      906
      of the Sarbanes-Oxley Act of 2002, that:




The
      Report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and




The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Company.






/s/
      Kevin
      Ericksteen


Kevin
      Ericksteen


Chief
      Executive Officer and Chief Financial Officer




Date: October
      10, 2007
**Exhibit 23.2**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMWe hereby consent to the incorporation by reference in the Registration Statements on Form S-8(Nos. 333-125862, 333-107659, 333-73904, 333-55978, 333-53446, 333-32096, 333-32092 and 333-65923)and Form S-3 (No. 333-132672) of Hanover Compressor Company of our report dated February 28, 2006relating to the financial statements, financial statement schedule, management’s assessment of theeffectiveness of internal control over financial reporting and the effectiveness of internalcontrol over financial reporting, which is incorporated by referencein this Form 10-K/A (Amendment No. 1)./s/ PricewaterhouseCoopers LLP
EXHIBIT 32.2
                            CERTIFICATION PURSUANT TO
                                 18 U.S.C. 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly  Report of UNITECH ENERGY CORP. (the "Company")
on Form  10-QSB  for the  period  ended  January  31,  2005,  as filed  with the
Securities and Exchange  Commission on the date hereof (the "Report"),  I, James
Durward, Chief Executive Officer of the Company,  certify, pursuant to 18 U.S.C.
1350,  as adopted  pursuant  to Section 906 of the  Sarbanes-Oxley  Act of 2002,
that:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and

The  information  contained  in the  Report  fairly  presents,  in all  material
respects, the financial condition and results of operations of the Company.


                                /s/ James Durward
                               --------------------------
Date: April 21, 2005                James Durward
                                    Chief Executive Officer
================================================================================


                                  Exhibit 32.1


                            CERTIFICATION PURSUANT TO

                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




In  connection  with the Quarterly  Report of Tari Inc. (the  "Company") on Form
10-QSB for the period ended  December 31, 2005 as filed with the  Securities and
Exchange Commission on the date hereof (the "Report"),  the undersigned,  in the
capacities and on the dates indicated  below,  hereby  certifies  pursuant to 18
U.S.C.  Section 1350, as adopted  pursuant to Section 906 of the  Sarbanes-Oxley
Act of 2002, that to his knowledge:



1.       The Report fully complies with the  requirements  of Section 13(a) or
         15(d) of the Securities  Exchange Act of 1934; and

2.       The  information  contained in the Report  fairly  presents,  in all
         material  respects,  the financial condition and results of operations
         of the Company.



Date:  March 13, 2007

/s/ Theodore Tsagkaris

--------------------------------
Theodore Tsagkaris
President, C.E.O. and Director
(Principal Executive Officer)
```

[Congressional Record Volume 158, Number 124 (Friday, September 14, 2012)]
[Extensions of Remarks]
[Pages E1535-E1536]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

               IN RECOGNITION OF BARCELONETA, PUERTO RICO

                                 ______
                                 

                        HON. FRANK PALLONE, JR.

                             of new jersey

                    in the house of representatives

                       Friday, September 14, 2012

  Mr. PALLONE. Mr. Speaker, I rise today to celebrate Barceloneta, 
Puerto Rico on its recognition at the Puerto Rican Heritage Statewide 
Parade of New Jersey's 51st Annual

[[Page E1536]]

Banquet Gala and Puerto Rican Ilustres. Please join me in welcoming the 
representatives of Barceloneta to the State of New Jersey.
  Founded in 1881, Barceloneta is named for its founder Bonocio Llenza 
Feliu's hometown of Barcelona, Spain. Due to the vast pineapple 
plantations across much of the town, it acquired the nickname of La 
Ciudad de las Pinas, or pineapple city. Barceloneta is located at the 
northern end of Puerto Rico, along the Atlantic Ocean and is traversed 
by the Grande de Manati River.
  Today, Barceloneta is known as the Industrial City as it once served 
as the largest pharmaceutical complex in the world with 14 industries 
present. It is an ideal location for the facilities because it has 
underground water reservoirs and the purity of Barceloneta's water 
requires little treatment to produce their products. Many manufacturers 
remain today, including Merck Sharp and Dohme; Pfizer; and Abbott 
Laboratories. Barceloneta is a unique commercial area with the first 
and one of the largest outlet malls in Puerto Rico, which also serves 
as a travel destination. Its tourism is also bolstered by its famous 
black sand beaches, most popular among them Playa La Palmita, Playa 
Puerto de las Vacas and Playa Las Criollas.
  Many notable individuals hail from Barceloneta, including Sixto 
Escobar, Puerto Rico's first boxing world champion. The Honorable Wanda 
J. Rosario Soler was elected as Barceloneta's first female mayor in 
2012. Mayor Rosario Soler is focused on economic development and 
tourism to ensure the continued success of Barceloneta.
  Mr. Speaker, once again, please join me in celebrating Barceloneta, 
Puerto Rico and thanking the Puerto Rican Heritage Statewide Parade of 
New Jersey for honoring the town at its 51st Annual Banquet Gala and 
Puerto Rican Ilustres.

                          ____________________
```
Agreement dated January 21, 2005 with Santoy Resources Ltd.




 

THIS
AGREEMENT dated for reference the 21 day of January , 2005

 

BETWEEN:

 

ALMADEN
MINERALS LTD.,
a corporation with a place of business at 1103 - 750 West Pender
Street,

Vancouver,
British Columbia V6C 2T8

 

(“Almaden”)

 

AND:

 

SANTOY
RESOURCES LTD.,
a corporation with a place of business at Suite 1116 - 925 West Georgia
Street,

Vancouver,
British Columbia V6C 3L2

 

(“Santoy”)

 

WHEREAS:

 

 

	A.  	
      Santoy
      (as Successor to Troymin Resources Ltd.) is the beneficial holder of a 25%
      undivided but unrecorded interest in those mineral properties known as
      Prospector Mountain and more particularly described in Schedule “A” and
      hereinafter referred to as the “Property
Interest”.






NOW
THEREFORE in consideration of the sum of ten dollars ($ 10.00) of lawful money
of Canada now paid by Almaden to Santoy and other good and valuable
consideration ( the receipt whereof is by Santoy hereby acknowledges) Santoy
hereby transfers, releases and quit claims to Almaden absolutely all right title
and interest in and to the Property Interest

This
Agreement shall be binding upon and inure to the benefit of the parties and
their respective successors and assignees. 




 

IN
WITNESS WHEREOF the parties have executed this Agreement as of the 21 day of
January, 2005.





	
      ALMADEN
      MINERALS LTD.
	 	 
	
       

      Per:
	
      “Duane
      Poliquin”
	 	 	 
	 	
      Authorized
      Signatory
	 	 	 










	
      SANTOY
      RESOURCES LTD..
	 	 
	
       

      Per:
	
      “Ronald
      Netolitzky)
	 	 	 
	 	
      Authorized
      Signatory
```

[Congressional Record Volume 158, Number 121 (Tuesday, September 11, 2012)]
[House]
[Page H5775]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

                            9/11 ANNIVERSARY

  (Ms. HAHN asked and was given permission to address the House for 1 
minute.)
  Ms. HAHN. As we mark yet another anniversary of a September morning 
that dawned just as any other, we are first and foremost called to 
remember; but as we remember the fear and the grief of a day born of 
unfathomable hate, we remember, too, the impossible heroism of so many 
of our fellow Americans.
  We remember the firefighters and the police officers who ran into the 
burning buildings to get others out. We remember the brave men and 
women of Flight 93, who, in learning of the attacks throughout the 
country, decided they would give their lives that others might live.
  We remember those early days when we came out of our homes and joined 
together with our neighbors, with flags and candles, united as one 
American family and when bitter political adversaries stood on the 
steps of this Capitol and put their arms around each other and sang 
``God Bless America.''
  But we shouldn't have to look back to feel that again. For the sake 
of those who died, for the sake of all those living and for all those 
yet to be born, let's come together in this House. Let's not be the do-
nothing Congress. In honor of all Americans, let's come together and 
work for the good of this country.

                          ____________________
```
Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the
Annual Report of NB&T Financial Group, Inc. (the Company, on Form 10-K for the period ended December 31, 2010, dated the date of this Certification (the Report), I, Craig F. Fortin, the Senior Vice President and
Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition
and results of operations of the Company.



|                     |  |  |  |                                                  
|-------------------- |  |  |  | -------------------------------------------------
|Date: March 15, 2011 |  |  |  | /S/    CRAIG F.
FORTIN                           
|                     |  |  |  | Craig F. Fortin                                  
|                     |  |  |  | Senior Vice President and Chief Financial Officer



94
EXHIBIT 31.1

CERTIFICATION

I, Tom W. Ward, certify that:

1.   I have reviewed this 10-K Report of Exabyte Corporation;

2.   Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.   Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.   The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a)   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)   Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

c)   Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and 

5.   The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a)   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)   Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.

Dated:  March 31, 2004

/s/  TOM W. WARD
March 21, 2014

CENTER FOR VETERINARY BIOLOGICS NOTICE NO. 14-06

TO: Biologics Licensees, Permittees, and Applicants

Directors, Center for Veterinary Biologics

Veterinary Services Leadership Team

FROM: Steven A. Karli /s/ Steven A. Karli

Acting Director

SUBJECT: Safety Data to Support Using Multiple Strains of Potentially 

 Immunosuppressive Viruses in the Same Modified Live Product

I. PURPOSE

The purpose of this Notice is to inform manufacturers that for certain agents, if 

combined with other agents in a modified live combination product, typical 

backpassage and field safety studies may not be sufficient.

II. BACKGROUND

The 1913 Virus Serum Toxin Act as amended by the 1985 Food Security Act,

authorizes the USDA to ensure all veterinary biologics for sale and distribution in 

the United States are not worthless, contaminated, dangerous or harmful. The 

impact of multiple strains of potentially immunosuppressive agents on the immune 

system, particularly of neonates, is not well understood. Supplemental safety data 

may be required for certain proposed modified live products, to ensure safety.

III. POLICY

To assess the immunosuppressive effects of combining multiple potentially 

immunosuppressive agents in the same modified live product, additional safety data 

may be required, to ensure that new products are safe as previously licensed 

products. Agents may be considered immunosuppressive based on data published in 

scientific literature. Although data generated from backpassage and field safety 

studies are minimum requirements for modified live products, additional safety data 

may be required. An example of a new product that may require additional studies 

would be a modified live Bovine Virus Diarrhea vaccine that includes additional 

strains in a combination that has not been previously approved for the proposed 

route of administration. Reviewers will provide recommendations for specific 

products when developing product licensing plans.

Animal and Plant

Health Inspection

Service

Veterinary Services

Center for Veterinary 

Biologics

1920 Dayton Avenue

PO Box 844

Ames, IA 50010

(515) 337-6100

An Equal Opportunity Provider and Employer
CENTER FOR VETERINARY BIOLOGICS NOTICE NO. 14-06

Page 2

IV. IMPLEMENTATION/ APPLICABILITY

This change is effective as of the date of this Notice. This policy applies to new products 

only.

 An Equal Opportunity Provider and Employer